Subscribe Free
in Maintenance

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK’s leading ground handler, Dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).

 

The UK MHRA granted Dnata full Wholesaler Dealer Authorisation (WDA) after Dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise Dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within Dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. Dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, Dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said Dnata UK CEO Gary Morgan. 

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector. ”

 

* required field

Post a comment

Other Stories
Advertisement
Latest News

Etihad Airways most punctual Middle Eastern carrier in the first seven months of 2019

Etihad Airways was the most punctual Middle Eastern carrier in the first seven months of 2019.

MEBAA Show Morocco gearing up for September event

Business aviation exhibitors across the world are keen to take advantage of the region’s opportunities by promoting their products and services at the MEBAA Show Morocco, taking place 25-26 September at Marrakech Menara Airport.

DXB welcomes 41.3 million passengers in the first half of 2019

Dubai International (DXB) welcomed 41.3 million passengers in the first half of 2019, maintaining its position as the world’s largest international airport by traffic volume.

Pakistan and India Independence Days celebrated at Abu Dhabi International Airport

Visitors to Abu Dhabi International Airport (AUH) from Pakistan and India were greeted by the green, white and saffron colours of their national flags, and steaming cups of Karak chai, to commemorate the Independence days of the two

Embraer releases second quarter results

Embraer delivered 26 commercial and 25 executive (19 light and 6 large) jets during 2Q19, compared to 28 commercial jets and 20 executive (15 light and 5 large) jets in 2Q18.

Abu Dhabi Airports completes preparations for the return of Hajj pilgrims

Abu Dhabi International Airport has completed preparations for the return of the Hajj pilgrims from Mecca and Medina over the upcoming weekend.

MEBCONSK1607240919
See us at
AVAFA20BT2607050320MEBCONBT1607240919BIDEC BT0108301019DIAC19_BT264161119MEBAAMORBT2006260919Dubai AS BT2006211119